Collectively, our findings identify an unappreciated secretin signaling in the central neural system for the regulation of energy and bone metabolism, which may serve as a new target for the clinical management of obesity and osteoporosis. The gene discussed is SCT; the disease is obesity due to melanocortin 4 receptor deficiency.